Controlled drug release from polyelectrolyte-drug conjugate nanoparticles

被引:17
作者
Catarata, Ruginn [1 ]
Azim, Nilab [1 ,2 ]
Bhattacharya, Santanu [3 ]
Zhai, Lei [1 ,2 ,4 ]
机构
[1] Univ Cent Florida, NanoSci Technol Ctr, Orlando, FL 32826 USA
[2] Univ Cent Florida, Dept Chem, Orlando, FL 32816 USA
[3] Mayo Clin, Coll Med & Sci, Dept Biochem & Mol Biol, Dept Physiol & Biomed Engn, Jacksonville, FL 32224 USA
[4] Univ Cent Florida, Dept Mat Sci & Engn, Orlando, FL 32816 USA
关键词
NANOMEDICINE; CANCER; GEMCITABINE; DELIVERY; THERAPY; OPPORTUNITIES; CHALLENGES; HYDROGELS; POLYMERS; PANCREAS;
D O I
10.1039/d0tb00012d
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
Encapsulating drugs in functional nanoparticles provides controlled and targeted release of drugs. In this study, a general approach for encapsulating hydrophobic drugs in polyelectrolyte nanoparticles was developed for a controlled drug release. Gemcitabine (GEM), an anticancer drug for pancreatic ductal adenocarcinoma (PDAC), was used as a model drug to produce poly(acrylic acid) (PAA)-GEM conjugate nanoparticles to achieve a controlled release of GEM in cells. The PAA-GEM conjugate nanoparticles were fabricated by coupling GEM onto PAA through the formation of amide bonds. The hydrophobic interactions of GEM molecules induced the formation of the nanoparticles with the GEM core and PAA shell. Fabrication conditions such as the PAA/GEM ratio and pH were optimized to achieve high structure stability and drug loading efficiency. The size and surface charge of the nanoparticles were characterized by transmission electron microscopy (TEM), dynamic light scattering (DLS) and zeta potential measurement. The optimized PAA-GEM nanoparticles had a size around 12 nm, 30 nm and 60 nm in dry state, water, and phosphate buffered saline (PBS), respectively. The encapsulation efficiency was 29.29 +/- 1.7%, and the loading capacity was 9.44 +/- 0.46%. Less than 7% GEM was released from the PAA-GEM nanoparticles after 96 hour incubation in phosphate buffered saline. The cytotoxic efficacy of the PAA-GEM nanoparticles in cancer cells was investigated through viability studies of PANC-1, a human pancreatic cancer cell line. It was found that the PAA-GEM nanoparticles had more than a 48 hour delay of releasing GEM and had the same cytotoxic efficacy in PANC-1 cells as free GEM. The uptake of the PAA-GEM nanoparticles by PANC-1 cells was investigated using PAA-GEM labeled by rhodamine G6. Fluorescence and bright field overlay images indicated that the PAA-GEM nanoparticles were taken up by PANC-1 cells within 2 hours. It is believed that the PAA-GEM nanoparticles were decomposed in PANC-1 cells and GEM was released from the nanoparticles.
引用
收藏
页码:2887 / 2894
页数:8
相关论文
共 71 条
[31]   Biodistribution of Self-Assembling Polymer-Gemcitabine Conjugate after Systemic Administration into Orthotopic Pancreatic Tumor Bearing Mice [J].
Kattel, Krishna ;
Mondal, Goutam ;
Lin, Feng ;
Kumar, Virender ;
Mahato, Ram I. .
MOLECULAR PHARMACEUTICS, 2017, 14 (05) :1365-1372
[32]   Long-term monitoring for nanomedicine implants and drugs [J].
Kendall, Michaela ;
Lynch, Iseult .
NATURE NANOTECHNOLOGY, 2016, 11 (03) :206-+
[33]   Sequence dependent effect of paclitaxel on gemcitabine metabolism in relation to cell cycle and cytotoxicity in non-small cell lung cancer cell lines [J].
Kroep, JR ;
Giaccone, G ;
Tolis, C ;
Voorn, DA ;
Loves, WJP ;
van Groeningen, CJ ;
Pinedo, HM ;
Peters, GJ .
BRITISH JOURNAL OF CANCER, 2000, 83 (08) :1069-1076
[34]  
Lee Joonseok, 2016, Nanomedicine (Lond), V11, P5, DOI 10.2217/nnm.15.187
[35]   Not just for tumor targeting: unmet medical needs and opportunities for nanomedicine [J].
Lepeltier, Elise Anne ;
Nuhn, Lutz ;
Lehr, Claus-Michael ;
Zentel, Rudolf .
NANOMEDICINE, 2015, 10 (20) :3147-3166
[36]   Targeting cancer cells in the tumor microenvironment: opportunities and challenges in combinatorial nanomedicine [J].
Linton, Samuel S. ;
Sherwood, Samantha G. ;
Drews, Kelly C. ;
Kester, Mark .
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2016, 8 (02) :208-222
[37]  
McCarroll JA, 2014, FRONT PHYSIOL, V5, DOI [10.3389/fphys.2014.00141, 10.3389/fphys.2014.00002]
[38]   Mathematical Modeling of Release Kinetics from Supramolecular Drug Delivery Systems [J].
Mircioiu, Constantin ;
Voicu, Victor ;
Anuta, Valentina ;
Tudose, Andra ;
Celia, Christian ;
Paolino, Donatella ;
Fresta, Massimo ;
Sandulovici, Roxana ;
Mircioiu, Ion .
PHARMACEUTICS, 2019, 11 (03)
[39]   Complement Propriety and Conspiracy in Nanomedicine: Perspective and a Hypothesis [J].
Moghimi, Seyed Moein .
NUCLEIC ACID THERAPEUTICS, 2016, 26 (02) :67-72
[40]  
Moghimi SM, 2001, PHARMACOL REV, V53, P283